News

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.

Microbes in the mammalian gut can significantly change their hosts’ amino acid and glucose metabolism, acting almost like an extra liver, according to a new preclinical study by Weill Cornell Medicine investigators.

Dr. Ashley Nelson, an assistant professor of immunology research in the Department of Pediatrics at Weill Cornell Medicine, has received a 2023 Hartwell Individual Biomedical Research Award from The Hartwell Foundation.

Dr. Adam D. Cheriff, a physician and healthcare executive with more than 20 years of leadership experience, has been named the new chief operating officer of Weill Cornell Medicine's Physician Organization, effective May 1. 

Dr. Carl Nathan, chair of the department of microbiology and immunology and the R.A. Rees Pritchett Professor of Microbiology at Weill Cornell Medicine, answers questions about interferon-γ's history and future.

Cornell University President Martha Pollack and Dr. Robert A. Harrington, Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, sent the following message on Apr. 22 to the Weill Cornell Medicine community.

For the second year in a row, Weill Cornell Medicine’s Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine has topped Newsweek’s list of America’s Best Fertility Clinics.

Researchers at Weill Cornell Medicine have developed a powerful, new technique to generate “movies” of changing protein structures at speeds of up to 50 frames per second.

Women are at higher risk of death when undergoing heart bypass surgery than men. Researchers at Weill Cornell Medicine have determined that this disparity is mediated, to a large extent, by intraoperative anemia—the dilution of red blood cells during surgery.

Treatment for rheumatoid arthritis (RA) has come a long way in recent years. In many cases, a battery of...

A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms. 

Investigators at Weill Cornell Medicine have assembled the most comprehensive atlas to date of messenger RNA (mRNA) variants in the mouse and human brain, which will be important in understanding brain development, neuron specialization and other brain functions.

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer's disease and frontotemporal dementia. 

Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural.

A Lancet Psychiatry commission with global membership, co-led by Dr. Beth McGinty, chief of the Division of Health Policy and Economics and the Livingston Farrand Professor of Population Health Sciences at Weill Cornell Medicine, presents strategies for conducting research to help narrow the mental health implementation gap.   

Awards, honors and achievements for the month of March.

A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients.

A collaboration between Dr. Jedd Wolchok, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, and Dr. Yelena Janjigian, chief of the gastrointestinal oncology service at Memorial Sloan Kettering Cancer Center, is looking to transform the care of gastroesophageal cancer (GEC) patients with untreatable disease – earning the pair a grant from Stand Up To Cancer® (SU2C) as a part of the SU2C-Torrey Coast Foundation Gastroesophageal Cancer Dream Team Collective.

Researchers at Weill Cornell Medicine have discovered a protein that plays a critical role in clearing collagen from tissue and may be a therapeutic target to help prevent fibrosis, scar tissue that interferes with organ function.

The 2024 Health Hackathon brought together 185 students with diverse backgrounds from Cornell and 26 other universities—in just 36 hours, they addressed critical safety challenges facing patients today.